Patents by Inventor Pascale RICHOMME

Pascale RICHOMME has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR CONTROLLING PHYTOPATHOGENIC INFECTIONS
    Publication number: 20240389587
    Abstract: A phytopharmaceutical method for treating a plant organ affected by a phytopathogenic fungal strain. The method includes the steps of applying on the plant organ a composition including at least one xanthone UPR (Unfolded Protein Response) inhibitor, preferably, an IRE-1 (Inositol-Requiring Enzyme 1) inhibitor, in a sub-effective amount. Also, a phytopharmaceutical composition including at least one UPR (Unfolded Protein Response) inhibitor in a sub-effective amount.
    Type: Application
    Filed: November 30, 2022
    Publication date: November 28, 2024
    Applicants: INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (INRAE), AGROCAMPUS OUEST (Institut national supérieur des sciences agronomiques, agro-alimentaires,, UNIVERSITÉ D'ANGERS
    Inventors: Nelly BATAILLÉ-SIMONEAU, Thomas CHARPENTIER, Thomas GUILLEMETTE, Anne-Marie LE RAY, Pascal RICHOMME-PENIGUEL, Philippe SIMONEAU, Guillaume VIAULT
  • POTENTIATING AGENTS FOR PROTECTING PLANTS FROM FUNGAL INFECTIONS
    Publication number: 20200002717
    Abstract: Disclosed is a method for preventing, controlling or treating a fungal infection on a plant. The method includes applying to such plant organ a non-fungicidal amount or a potentiating amount of a composition including a potentiating agent of a plant defense molecule, in association with a phytopharmaceutical vehicle.
    Type: Application
    Filed: September 9, 2019
    Publication date: January 2, 2020
    Inventors: Philippe SIMONEAU, Thomas GUILLEMETTE, Pascal RICHOMME, Jean-Jacques HELESBEUX
  • TOCOTRIENOL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD OF USE IN 5-LIPOXYGENASE RELATED DISEASES
    Publication number: 20190144413
    Abstract: The present invention relates to compounds of formula (III) or to compounds of formula (IV) wherein R1, R2, R3 and R4 are as defined in the claims, and their use in therapeutic treatments of 5-lipoxygenase related diseases such as chronic airway inflammatory or dermatological disorders.
    Type: Application
    Filed: August 26, 2016
    Publication date: May 16, 2019
    Inventors: Pascal RICHOMME, Jean-Jacques HELESBEUX, David GUILET, Denis SERAPHIN, Hermann STUPPNER, Birgit WALTENBERGER, Daniela SCHUSTER, Veronika Sophie TEMML, Andreas KOEBERLE, Oliver WERZ
  • ANTI-GLYCATION AGENT COMPRISING A GARCINIA KOLA EXTRACT OR FRACTION
    Publication number: 20140142171
    Abstract: An anti-glycation agent includes a Garcinia kola extract or fraction. The compositions including the extract or the fraction are used to inhibit the glycation of proteins, in particular the glycation of skin proteins involved in cutaneous aging. A method for determining the activity of compounds for inhibiting the glycation of cutaneous proteins, in particular for inhibiting the glycation of collagen is also described.
    Type: Application
    Filed: November 19, 2013
    Publication date: May 22, 2014
    Applicants: LABORATOIRE SHIGETA, UNIVERSITE D'ANGERS
    Inventors: Severine DERBRE, Sylvie MOREL, Pascale RICHOMME, Alexis Kaatio TOURE